1. Brugarolas A, Gratia Marco M, Garcia Miralles MT, Ribas A, Valle M, Izarguzaga I (to be published) Prevention of long term iron associated toxicity of quelamycin by deferoxamine. Cancer Treat Rep
2. Brugarolas A, Lacave AJ, Gratia Marco M, Buesa JM, Cortes H, Gosalvez M (to be published) Quelamycin. Cancer Chemother Rev
3. Brugarolas A, Pachon N, Perez-Llanderal JA, Lacave AJ, Buesa JM, Gratia Marco M (1978) Phase I clinical trial of quelamycin. Cancer Treat Rep 62:1527–1534
4. Brugarolas A, Perez Llanderal JA, Garcia Miralles MT, Lacave AJ, Gratia Marco M, Izquierdo JM, Rodriguez Lloviran AL, Ribas A (1979) Iron toxicity studies of quelamycin. Cancer Treat Rep 63:909–913
5. Cortés-Funes H, Gosálvez M, Moyano A, Manas A, Mendiola C (1979) Early trial clinical with quelamycin. Cancer Treat Rep 63:903–908